How can MRD and disease be assessed in routine practice?
Open questions in the use of imaging techniques for assessing response in multiple myeloma
Renal complications in multiple myeloma - characteristics and treatment
Why patients should be involved in evaluating novel drugs in multiple myeloma
Are we ready to use minimal residual disease (MRD) to direct multiple myeloma therapy?